Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Inventory (2020 - 2025)

RxSight (RXST) has disclosed Inventory for 6 consecutive years, with $33.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory rose 52.35% year-over-year to $33.5 million, compared with a TTM value of $33.5 million through Dec 2025, up 52.35%, and an annual FY2025 reading of $33.5 million, up 52.35% over the prior year.
  • Inventory was $33.5 million for Q4 2025 at RxSight, up from $30.4 million in the prior quarter.
  • Across five years, Inventory topped out at $33.5 million in Q4 2025 and bottomed at $8.1 million in Q4 2021.
  • Average Inventory over 5 years is $18.6 million, with a median of $18.5 million recorded in 2023.
  • The sharpest move saw Inventory fell 5.31% in 2021, then surged 113.28% in 2023.
  • Year by year, Inventory stood at $8.1 million in 2021, then skyrocketed by 89.87% to $15.5 million in 2022, then increased by 12.62% to $17.4 million in 2023, then increased by 26.34% to $22.0 million in 2024, then soared by 52.35% to $33.5 million in 2025.
  • Business Quant data shows Inventory for RXST at $33.5 million in Q4 2025, $30.4 million in Q3 2025, and $26.7 million in Q2 2025.